Alini D V Sabino1, Marcos Hortes N Chagas2, Flávia L Osório3,4. 1. Medical School of Ribeirão Preto, São Paulo University, Avenida dos Bandeirantes, 3900, Ribeirão Preto, SP, 14048-900, Brazil. 2. Center for Biological and Health Sciences, Federal University of São Carlos, São Carlos, Brazil. 3. Medical School of Ribeirão Preto, São Paulo University, Avenida dos Bandeirantes, 3900, Ribeirão Preto, SP, 14048-900, Brazil. flaliosorio@gmail.com. 4. National Institute for Science and Technology (INCT-TM, CNPq), Brasília, Brazil. flaliosorio@gmail.com.
Abstract
RATIONALE: Individuals with music performance anxiety (MPA) present physical, behavioral, and cognitive manifestations of anxiety, in addition to information processing deficits, especially in facial emotion recognition (FER). OBJECTIVES: To assess the effects of a single dose of intranasal oxytocin (24 IU) on FER in a sample of musicians with high and low MPA (primary outcome), as well as indicators of mood/anxiety and self-assessed performance (secondary outcomes). METHODS: Crossover, randomized, double-blind, placebo-controlled trial involving 43 male musicians with different levels of MPA. Participants completed a static facial emotion recognition task and self-rated mood and performance scales. Data were analyzed using ANOVA 2 × 0 for crossover trials and the Omnibus test (measure of separability between intervention and carryover effects). RESULTS: Only musicians with high MPA treated with oxytocin had a higher accuracy in the recognition of happiness (p < 0.03; d > 0.72). No effects of oxytocin were found on mood indicators or on self-perceived performance, regardless of MPA level. CONCLUSIONS: The results indicate possible benefits of the acute treatment with oxytocin in MPA, which may improve the management of this common and disabling condition that affects professional musicians. The appropriate perception of positive feedback may increase confidence and feelings of social acceptance, reducing symptoms associated with the condition. The lack of effects on mood/anxiety and cognition may be explained by the context-dependent characteristic of the effects of oxytocin, since the experiment did not represent an actual situation of social threat. TRIAL REGISTRATION: Brazilian Clinical Trials Registry (Registro Brasileiro de Ensaios Clínicos): No. RBR-9cph2q.
RCT Entities:
RATIONALE: Individuals with music performance anxiety (MPA) present physical, behavioral, and cognitive manifestations of anxiety, in addition to information processing deficits, especially in facial emotion recognition (FER). OBJECTIVES: To assess the effects of a single dose of intranasal oxytocin (24 IU) on FER in a sample of musicians with high and low MPA (primary outcome), as well as indicators of mood/anxiety and self-assessed performance (secondary outcomes). METHODS: Crossover, randomized, double-blind, placebo-controlled trial involving 43 male musicians with different levels of MPA. Participants completed a static facial emotion recognition task and self-rated mood and performance scales. Data were analyzed using ANOVA 2 × 0 for crossover trials and the Omnibus test (measure of separability between intervention and carryover effects). RESULTS: Only musicians with high MPA treated with oxytocin had a higher accuracy in the recognition of happiness (p < 0.03; d > 0.72). No effects of oxytocin were found on mood indicators or on self-perceived performance, regardless of MPA level. CONCLUSIONS: The results indicate possible benefits of the acute treatment with oxytocin in MPA, which may improve the management of this common and disabling condition that affects professional musicians. The appropriate perception of positive feedback may increase confidence and feelings of social acceptance, reducing symptoms associated with the condition. The lack of effects on mood/anxiety and cognition may be explained by the context-dependent characteristic of the effects of oxytocin, since the experiment did not represent an actual situation of social threat. TRIAL REGISTRATION: Brazilian Clinical Trials Registry (Registro Brasileiro de Ensaios Clínicos): No. RBR-9cph2q.
Entities:
Keywords:
Cognition; Facial emotion; Mood; Music performance anxiety; Oxytocin
Authors: Fosco Bernasconi; Michael Kometer; Thomas Pokorny; Erich Seifritz; Franz X Vollenweider Journal: Eur Neuropsychopharmacol Date: 2015-01-17 Impact factor: 4.600
Authors: Gail A Alvares; Nigel T M Chen; Bernard W Balleine; Ian B Hickie; Adam J Guastella Journal: Psychoneuroendocrinology Date: 2012-05-20 Impact factor: 4.905
Authors: Sarah Bate; Rachel Bennetts; Benjamin A Parris; Markus Bindemann; Robert Udale; Amanda Bussunt Journal: Soc Cogn Affect Neurosci Date: 2014-11-29 Impact factor: 3.436
Authors: Jennifer A Bartz; Jamil Zaki; Niall Bolger; Eric Hollander; Natasha N Ludwig; Alexander Kolevzon; Kevin N Ochsner Journal: Psychol Sci Date: 2010-09-20